NCT04812860View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.

PHASE2CompletedINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

January 25, 2021

Study Completion Date

January 25, 2021

Conditions

Moderate to Severe Acute Pain

Interventions

DRUG

HR18042

Tablet, Dosing frequency: once daily, Route of administration: oral

DRUG

HR18042

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

HR18042

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

Tramadol hydrochloride ER

Tablet,Dosing frequency: once daily, Route of administration: oral

DRUG

Placebo

Tablet,Dosing frequency: once daily, Route of administration: oral

Trial Locations (1)

610041

West China Hospital of Stomatology Sichuan University, Chengdu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04812860 - A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth. | Biotech Hunter | Biotech Hunter